Market Slips After Rising Briefly, Dendreon Still Soaring

Despite the GDP growth we’ve experienced here in the US, downgrades on Greek banks by Moody’s soured the mood quickly. After a brief spurt upward, the Dow fell and is currently down 45 points at 11,121.

Goldman Sachs (GS) is down 7.3% to $148 and Dendreon (DNDN)  – chart below -is still climbing after yesterday’s FDA-approval, currently up 8.5% to $54.48.

DNDN Chart Apr 30th

Photo: Google Finance

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at